...
search icon
qgen-img

Qiagen NV, Common Stock

QGEN

NYQ

$40.71

-$0.73

(-1.76%)

1D
Industry: Life Sciences Tools & Services Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$9.07B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
107.1316
Volume info-icon
This is the total number of shares traded during the most recent trading day.
0
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
2.94%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.62
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$37.63 L
$47.96 H
$40.71

About Qiagen NV, Common Stock

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, such as assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables, such as short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments; bioinformatics solutions; and custom laboratory and genomic services. The company provides software-as-a-service. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. The company was founded in 1984 and is headquartered in Venlo, the Netherlands. more

Industry: Life Sciences Tools & ServicesSector: Health Care

Returns

Time FrameQGENSectorS&P500
1-Week Return1.65%0.44%0.24%
1-Month Return2.24%-7.69%-7.32%
3-Month Return-13.96%-3.35%-12.05%
6-Month Return-7.29%-11.09%-9.73%
1-Year Return0.89%-2.13%5.05%
3-Year Return-17.38%-1.18%20.03%
5-Year Return-5.35%34.44%83.31%
10-Year Return46.99%84.87%153.54%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue1.87B2.25B2.14B1.97B1.98B[{"date":"2020-12-31","value":83.07,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":95.11,"profit":true},{"date":"2023-12-31","value":87.28,"profit":true},{"date":"2024-12-31","value":87.86,"profit":true}]
Cost of Revenue642.54M800.84M756.96M742.39M653.42M[{"date":"2020-12-31","value":80.23,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":94.52,"profit":true},{"date":"2023-12-31","value":92.7,"profit":true},{"date":"2024-12-31","value":81.59,"profit":true}]
Gross Profit1.23B1.45B1.38B1.22B1.32B[{"date":"2020-12-31","value":84.63,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":95.43,"profit":true},{"date":"2023-12-31","value":84.29,"profit":true},{"date":"2024-12-31","value":91.31,"profit":true}]
Gross Margin65.65%64.43%64.65%62.23%66.97%[{"date":"2020-12-31","value":98.02,"profit":true},{"date":"2021-12-31","value":96.21,"profit":true},{"date":"2022-12-31","value":96.54,"profit":true},{"date":"2023-12-31","value":92.92,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses682.94M792.97M808.34M777.68M1.23B[{"date":"2020-12-31","value":55.66,"profit":true},{"date":"2021-12-31","value":64.62,"profit":true},{"date":"2022-12-31","value":65.87,"profit":true},{"date":"2023-12-31","value":63.38,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income554.90M630.08M531.46M445.25M97.71M[{"date":"2020-12-31","value":88.07,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":84.35,"profit":true},{"date":"2023-12-31","value":70.66,"profit":true},{"date":"2024-12-31","value":15.51,"profit":true}]
Total Non-Operating Income/Expense(8.24M)(49.17M)(44.46M)4.71M47.61M[{"date":"2020-12-31","value":-17.32,"profit":false},{"date":"2021-12-31","value":-103.28,"profit":false},{"date":"2022-12-31","value":-93.38,"profit":false},{"date":"2023-12-31","value":9.89,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income154.93M625.83M512.60M429.81M121.15M[{"date":"2020-12-31","value":24.76,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":81.91,"profit":true},{"date":"2023-12-31","value":68.68,"profit":true},{"date":"2024-12-31","value":19.36,"profit":true}]
Income Taxes81.29M113.23M89.39M88.51M37.56M[{"date":"2020-12-31","value":71.79,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":78.94,"profit":true},{"date":"2023-12-31","value":78.16,"profit":true},{"date":"2024-12-31","value":33.17,"profit":true}]
Income After Taxes73.64M512.60M423.21M341.30M83.59M[{"date":"2020-12-31","value":14.37,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":82.56,"profit":true},{"date":"2023-12-31","value":66.58,"profit":true},{"date":"2024-12-31","value":16.31,"profit":true}]
Income From Continuous Operations359.19M512.60M423.21M332.48M83.59M[{"date":"2020-12-31","value":70.07,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":82.56,"profit":true},{"date":"2023-12-31","value":64.86,"profit":true},{"date":"2024-12-31","value":16.31,"profit":true}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income73.64M512.60M423.21M341.30M83.59M[{"date":"2020-12-31","value":14.37,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":82.56,"profit":true},{"date":"2023-12-31","value":66.58,"profit":true},{"date":"2024-12-31","value":16.31,"profit":true}]
EPS (Diluted)2.152.652.372.072.19[{"date":"2020-12-31","value":81.13,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":89.43,"profit":true},{"date":"2023-12-31","value":78.11,"profit":true},{"date":"2024-12-31","value":82.64,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

QGEN
Cash Ratio 2.12
Current Ratio 3.61
Quick Ratio 3.09

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

QGEN
ROA (LTM) 5.24%
ROE (LTM) 2.27%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

QGEN
Debt Ratio Lower is generally better. Negative is bad. 0.37
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.63

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

QGEN
Trailing PE 107.13
Forward PE 17.39
P/S (TTM) 4.45
P/B 2.51
Price/FCF 62
EV/R 4.66
EV/Ebitda 25.03
PEG 0.96

FAQs

What is Qiagen NV share price today?

Qiagen NV (QGEN) share price today is $40.71

Can Indians buy Qiagen NV shares?

Yes, Indians can buy shares of Qiagen NV (QGEN) on Vested. To buy Qiagen NV from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in QGEN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Qiagen NV be purchased?

Yes, you can purchase fractional shares of Qiagen NV (QGEN) via the Vested app. You can start investing in Qiagen NV (QGEN) with a minimum investment of $1.

How to invest in Qiagen NV shares from India?

You can invest in shares of Qiagen NV (QGEN) via Vested in three simple steps:

  • Click on Sign Up or Invest in QGEN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Qiagen NV shares
What is Qiagen NV 52-week high and low stock price?

The 52-week high price of Qiagen NV (QGEN) is $47.96. The 52-week low price of Qiagen NV (QGEN) is $37.63.

What is Qiagen NV price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Qiagen NV (QGEN) is 107.1316

What is Qiagen NV price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Qiagen NV (QGEN) is 2.51

What is Qiagen NV dividend yield?

The dividend yield of Qiagen NV (QGEN) is 2.94%

What is the Market Cap of Qiagen NV?

The market capitalization of Qiagen NV (QGEN) is $9.07B

What is Qiagen NV’s stock symbol?

The stock symbol (or ticker) of Qiagen NV is QGEN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top